PerspectiveStem Cells

Marketing of unproven stem cell–based interventions: A call to action

See allHide authors and affiliations

Science Translational Medicine  05 Jul 2017:
Vol. 9, Issue 397, eaag0426
DOI: 10.1126/scitranslmed.aag0426

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Commercial promotion of unsupported therapeutic uses of stem cells is a global problem that has proven resistant to regulatory efforts. Here, we suggest a coordinated approach at the national and international levels focused on engagement, harmonization, and enforcement to reduce the risks associated with direct-to-consumer marketing of unproven stem cell treatments.

View Full Text